BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang XZ, Mao HL, Zhang SJ, Sun L, Zhang WJ, Chen QZ, Wang L, Liu HC. lncRNA PCAT18 inhibits proliferation, migration and invasion of gastric cancer cells through miR-135b suppression to promote CLDN11 expression. Life Sci 2020;249:117478. [PMID: 32119960 DOI: 10.1016/j.lfs.2020.117478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Geng R, Zhong Z, Zhang Y, Ni S, Liu W, Du M, Bai J, Roy S. N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-32. [DOI: 10.1155/2022/2754836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liu J, Geng R, Ni S, Cai L, Yang S, Shao F, Bai J. Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC. Mol Ther Nucleic Acids 2022;27:1036-55. [PMID: 35228898 DOI: 10.1016/j.omtn.2022.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
3 Xu Y, Zheng J, Cai Z, Li W, Köhler J, Dai Y, Cheng X, Wu T, Zhang F, Wang H. Therapeutic Response-Based Reclassification of Multiple Tumor Subtypes Reveals Intrinsic Molecular Concordance of Therapy Across Histologically Disparate Cancers. Front Cell Dev Biol 2021;9:773101. [PMID: 34869372 DOI: 10.3389/fcell.2021.773101] [Reference Citation Analysis]
4 Li J. Dysregulated expression of claudins in cancer. Oncol Lett 2021;22:641. [PMID: 34386063 DOI: 10.3892/ol.2021.12902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Pan J, Huang Z, Xu Y. m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma. Front Cell Dev Biol 2021;9:671821. [PMID: 34268304 DOI: 10.3389/fcell.2021.671821] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
6 Li J, Sun L, Chen Y, Zhu J, Shen J, Wang J, Gu Y, Zhang G, Wang M, Shi T, Chen W. Gastric cancer-derived exosomal miR-135b-5p impairs the function of Vγ9Vδ2 T cells by targeting specificity protein 1. Cancer Immunol Immunother 2021. [PMID: 34159436 DOI: 10.1007/s00262-021-02991-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 He L, Wang J, Zhou L, Li X. LncRNA PCAT18 Promotes Non-Small Cell Lung Cancer Progression by Sponging miR-4319. Cancer Manag Res 2021;13:3761-74. [PMID: 34007211 DOI: 10.2147/CMAR.S298918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yang D, Li R, Xia J, Li W, Ma L, Ye L, Xue H. Long Noncoding RNA PCAT18 Upregulates SPRR3 to Promote Colorectal Cancer Progression by Binding to miR-759. Cancer Manag Res 2020;12:11445-52. [PMID: 33204157 DOI: 10.2147/CMAR.S272652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Lu H, Zhang Q, Sun Y, Wu D, Liu L. LINC00689 induces gastric cancer progression via modulating the miR-338-3p/HOXA3 axis. J Gene Med 2020;22:e3275. [PMID: 32926751 DOI: 10.1002/jgm.3275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]